biperiden has been researched along with Cancer of Head in 2 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Excerpt | Relevance | Reference |
---|---|---|
"Sixty-nine patients, irradiated for head and neck cancer with salivary glands included in the irradiation fields, were randomly assigned into three groups (A, B, and C)." | 2.69 | The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients. ( Budihna, M; Gaspersic, D; Rode, M; Smid, L; Soba, E, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rode, M | 4 |
Smid, L | 2 |
Budihna, M | 2 |
Soba, E | 2 |
Gaspersic, D | 1 |
Gassperssic, D | 1 |
2 trials available for biperiden and Cancer of Head
Article | Year |
---|---|
The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients.
Topics: Adult; Aged; Biperiden; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Age | 1999 |
The influence of pilocarpine and biperiden on pH value and calcium, phosphate, and bicarbonate concentrations in saliva during and after radiotherapy for head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Bicarbonates; Biperiden; Calcium; Female; Follow-Up Studies; Head | 2001 |